Recombia Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Recombia Biosciences, Inc. - overview
Established
2019
Location
Brisbane, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2019, Recombia Biosciences, Inc. operates as a Biotechnology company. Justin Smith (CEO & Head of Tech Development), Bob St. Onge and Lars Steinmetz are the co-founders of the company.
In September 2022, Recombia Biosciences was acquired by Lesaffre. The company is a spinout of Stanford Genome Technology Center. The company uses advanced high-throughput genome editing and synthetic biology technology to find ways to boost industrial microbes for producing a variety of sustainable products. The acquisition by Lesaffre in September 2022 intends to leverage Recombia Biosciences’ genome-editing technologies and accelerate the development of yeasts for sustainable production of fermented ingredients.
Current Investors
Lesaffre
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.recombia.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Recombia Biosciences, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Recombia Biosciences, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.